The impact of COVID-19 on people with multiple sclerosis: A comparison of Italian and United States cohorts.


Journal

Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 14 02 2022
revised: 02 05 2022
accepted: 13 05 2022
pubmed: 7 6 2022
medline: 29 6 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

The present cross-national study addressed the relationship among three pandemic-related variables and multiple sclerosis (MS) disability outcomes among people with MS in Italy and the United States (US). This cross-sectional web-based study was administered to 708 patients with MS from the US and Italy in late Spring through mid-Summer of 2020. Pandemic-related variables assessed worry, self-protection, and post-traumatic growth. The Performance Scales© assessed MS disability. Multivariate multiple regression models addressed, separately by country, the relationship among worry, protection, and post-traumatic growth with MS disability, after covariate adjustment. The Italian sample (n = 292) was younger and less disabled than the US group (n = 416). After covariate adjustment, all three pandemic-related variables were associated with MS disability outcomes in the US sample, but only worry and post-traumatic growth were associated in the Italian sample. Worse cognitive and depression symptoms were associated with worry, and lesser mobility disability was associated with endorsed growth in both countries. More disability variables were associated with worry and growth in the Italian sample. The pandemic's negative aspects were associated with worse disability in both countries, and reported post-traumatic growth was associated with lesser disability. These findings may suggest directions for clinical intervention.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
The present cross-national study addressed the relationship among three pandemic-related variables and multiple sclerosis (MS) disability outcomes among people with MS in Italy and the United States (US).
METHODS METHODS
This cross-sectional web-based study was administered to 708 patients with MS from the US and Italy in late Spring through mid-Summer of 2020. Pandemic-related variables assessed worry, self-protection, and post-traumatic growth. The Performance Scales© assessed MS disability. Multivariate multiple regression models addressed, separately by country, the relationship among worry, protection, and post-traumatic growth with MS disability, after covariate adjustment.
RESULTS RESULTS
The Italian sample (n = 292) was younger and less disabled than the US group (n = 416). After covariate adjustment, all three pandemic-related variables were associated with MS disability outcomes in the US sample, but only worry and post-traumatic growth were associated in the Italian sample. Worse cognitive and depression symptoms were associated with worry, and lesser mobility disability was associated with endorsed growth in both countries. More disability variables were associated with worry and growth in the Italian sample.
CONCLUSIONS CONCLUSIONS
The pandemic's negative aspects were associated with worse disability in both countries, and reported post-traumatic growth was associated with lesser disability. These findings may suggest directions for clinical intervention.

Identifiants

pubmed: 35661570
pii: S2211-0348(22)00400-X
doi: 10.1016/j.msard.2022.103888
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103888

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Carolyn E Schwartz (CE)

DeltaQuest Foundation, Inc., Concord, MA, USA; Departments of Medicine and Orthopaedic Surgery, Tufts University Medical School, Boston, MA, USA. Electronic address: carolyn.schwartz@deltaquest.org.

Bruce D Rapkin (BD)

Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.

Simona Bonavita (S)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Michela Bossa (M)

Behavioral Neuropsychology Laboratory, IRCCS S. Lucia Foundation, Rome, Italy.

Maria Chiara Buscarinu (MC)

Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy; Neuroimmunology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy.

Maria Grazia Grasso (MG)

Multiple Sclerosis Unit, IRCCS S. Lucia Foundation, Rome, Italy.

Maria Luca (M)

Department "GF Ingrassia", Section of Neurosciences, University of Catania, Catania, Italy; Centre for addiction, Via Pò 2, 95031, Adrano, Italy.

Agostino Nozzolillo (A)

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Ugo Nocentini (U)

Behavioral Neuropsychology Laboratory, IRCCS S. Lucia Foundation, Rome, Italy; Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH